The angiotensin II receptor blocker (ARB) candesartan cilexetil decreases portal vascular resistance in liver cirrhosis

被引：0
|
作者：
Ito, M
Hachiya, A
Nakano, S
Hanzawa, M
Katagiri, M
Kurita, T
Matsuzaki, H
Igarashi, Y
Iida, K
Miki, K
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83358-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A663 / A663
页数：1
相关论文
共 50 条
  • [21] A new class of diacidic nonpeptide angiotensin II receptor antagonists: Candesartan cilexetil
    Naka, T
    Kubo, K
    [J]. CURRENT PHARMACEUTICAL DESIGN, 1999, 5 (06) : 453 - 472
  • [22] Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4-5 chronic kidney disease
    Tamura, Yoshifuru
    Kosuga, Masahiro
    Yamashita, Masahiro
    Tomioka, Satoru
    Sasaki, Michiko
    Hikita, Tomoyuki
    Nakajima, Hideaki
    Kojima, Kenichiro
    Uchida, Shunya
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2008, 12 (04) : 256 - 263
  • [23] Efficiency of irbesartan, an angiotensin II receptor antagonist, on portal pressure and intrahepatic resistance in cirrhosis of the liver.
    Klein, CG
    Bergmannsheil, C
    Kalk, JF
    May, B
    Klein, CP
    [J]. HEPATOLOGY, 2000, 32 (04) : 523A - 523A
  • [24] Angiotensin II Receptor Blocker Candesartan Cilexetil, but Not Hydralazine Hydrochloride, Protects Against Mouse Cardiac Enlargement Resulting From Undernutrition In Utero
    Makoto Kawamura
    Hiroaki Itoh
    Shigeo Yura
    Haruta Mogami
    Tsuyoshi Fujii
    Naohiro Kanayama
    Ikuo Konishi
    [J]. Reproductive Sciences, 2009, 16 : 1005 - 1012
  • [25] Differences among angiotensin II type 1 receptor blockers: Characteristics of candesartan cilexetil
    Unger, T
    [J]. BLOOD PRESSURE, 2000, 9 : 14 - 18
  • [26] Angiotensin II Receptor Blocker Candesartan Cilexetil, but Not Hydralazine Hydrochloride, Protects Against Mouse Cardiac Enlargement Resulting From Undernutrition In Utero
    Kawamura, Makoto
    Itoh, Hiroaki
    Yura, Shigeo
    Mogami, Haruta
    Fujii, Tsuyoshi
    Kanayama, Naohiro
    Konishi, Ikuo
    [J]. REPRODUCTIVE SCIENCES, 2009, 16 (10) : 1005 - 1012
  • [27] Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in liver cirrhosis
    Schneider, AW
    Rambach, W
    Kuhn, R
    Kalk, JF
    Klein, CP
    [J]. GUT, 1997, 41 : A233 - A233
  • [28] Vascular Protecting Effect of Angiotensin Receptor Blocker (ARB) on the Radial Artery Graft
    Hata, Mitsumasa
    Sezai, Akira
    Niino, Tetsuya
    Yoda, Masataka
    Takayama, Tadateru
    Takemoto, Akiko
    Himi, Kazuhisa
    Shiono, Motomi
    Negishi, Nanao
    Minami, Kazutomo
    [J]. ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 14 (01) : 25 - 28
  • [29] Effects of candesartan, an angiotensin II receptor blocker, versus diet only on insulin resistance assessed by HOMA
    Kawai, T
    Tabata, M
    Shigihara, T
    Saisho, Y
    Hirose, H
    Shimada, A
    Saruta, T
    [J]. DIABETES, 2005, 54 : A527 - A527
  • [30] New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis
    Hidaka, Hisashi
    Kokubu, Shigehiro
    Nakazawa, Takahide
    Okuwaki, Yuusuke
    Ono, Kouji
    Watanabe, Masaaki
    Shibuya, Akitaka
    Saigenji, Katsunori
    [J]. HEPATOLOGY RESEARCH, 2007, 37 (12) : 1011 - 1017
12345